Scalp current therapy eased pain a touch, did nothing for sleep

Musculoskeletal pain is common, stubborn to treat and often disturbs sleep, so interest in drug-free options keeps growing. Transcranial alternating current stimulation, or tACS, passes a weak oscillating current through the scalp and has been emerging as a potential therapeutic option for pain management. Whether it actually reduces pain, whether any relief carries over into better sleep, and whether it is safe had not been comprehensively evaluated across the randomised evidence. This review set out to answer all three questions at once.

The reviewers searched seven major databases and other sources from inception until April 2026 for randomised controlled trials of tACS in adults with musculoskeletal pain. Two reviewers independently screened the studies, extracted the data and assessed risk of bias. Six trials involving 232 participants qualified. Results were pooled using a random-effects model, and the certainty of the evidence for each outcome was formally graded.

tACS significantly reduced pain intensity compared with control, though the pooled effect was modest in size. Sleep quality showed essentially no change, with the pooled estimate sitting almost exactly at zero. Adverse effects were mild and transient, and comparable to sham stimulation, which is reassuring on safety. The certainty of evidence was rated low for both the pain and sleep outcomes, meaning future trials could easily shift these estimates in either direction.

This places tACS among the non-invasive brain stimulation techniques with a genuine but modest early signal for pain. The null result for sleep is notable because pain and poor sleep so often travel together, yet on current evidence any pain relief did not carry over into better rest, though the reviewers stress the sleep evidence is especially thin. They call for well-designed trials with standardised outcome measures, condition-specific stimulation protocols and longer follow-up, all of which the small trials pooled here lacked.

This is a reason to keep an eye on tACS rather than to seek it out. The pain reduction was modest, came from a small pool of participants, and the reviewers themselves rated their confidence in the finding as low. Anyone hoping it would fix pain-disturbed sleep will find no support here, though the mild and short-lived side-effect profile is at least reassuring about how the technique has behaved in trials so far.